Androgen receptor splice variant V7 (AR-V7) in circulating tumor cells: a coming of age for AR splice variants?

Ann Oncol. 2015 Sep;26(9):1805-1807. doi: 10.1093/annonc/mdv311. Epub 2015 Jul 21.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Androstenes / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Biomarkers, Tumor / genetics*
  • Humans
  • Male
  • Neoplasm Recurrence, Local / genetics
  • Neoplasm Recurrence, Local / pathology
  • Neoplastic Cells, Circulating / pathology*
  • Nitriles
  • Phenylthiohydantoin / analogs & derivatives
  • Phenylthiohydantoin / therapeutic use
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology
  • Protein Isoforms / genetics
  • Receptors, Androgen / genetics*
  • Treatment Outcome

Substances

  • AR protein, human
  • Androstenes
  • Antineoplastic Agents
  • Benzamides
  • Biomarkers, Tumor
  • Nitriles
  • Protein Isoforms
  • Receptors, Androgen
  • Phenylthiohydantoin
  • enzalutamide
  • abiraterone